# Mineralys Therapeutics, Inc. — Form D

Mineralys Therapeutics, Inc. of RADNOR, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-13. The offering totals $118.0M, of which $118.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-06-13
- Form: D
- Accession: 0001567619-22-012734
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $118.0M
- Amount sold: $118.0M
- Investors: 23
- Date of first sale: 2022-06-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-448950

## Issuer

- Name: Mineralys Therapeutics, Inc.
- CIK: 0001933414
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 150 N. RADNOR CHESTER ROAD, RADNOR, PA, 19087
- Phone: (888) 378-6240

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Srinivas Akkaraju | Director | Palo Alto, CA |
| Alexander Asam | Director | Radnor, PA |
| Jon Congleton | Director | Radnor, PA |
| Derek DiRocco | Director | Boston, MA |
| Olivier Litzka | Director | Irvine, CA |
| Takeshi Takahashi | Director | Radnor, PA |
| Brian Taylor Slingsby | Director | Radnor, PA |
| Jon Congleton | Executive Officer | Radnor, PA |
| Adam Levy | Executive Officer | Los Gatos, CA |

## More

- [CIK 1933414 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1933414&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-22-012734.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.